Yehonatan Weinberger

6PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Nonlinear optics and spectroscopyVision scienceMolecular targetsOral and maxillofacial surgery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 20, 2025
Intra-arterial chemotherapy for retinoblastoma: a performance analysis.

Yehonatan Weinberger, Saloni Kapoor, Emily C Zabor

|Jul 14, 2023
3K3A-Activated Protein C Inhibits Choroidal Neovascularization Growth and Leakage and Reduces NLRP3 Inflammasome, IL-1β, and Inflammatory Cell Accumulation in the Retina.

Yehonatan Weinberger, Ivan Budnik, Yael Nisgav

|Nov 26, 2022
3K3A-Activated Protein C Prevents Microglia Activation, Inhibits NLRP3 Inflammasome and Limits Ocular Inflammation.

Dahlia Palevski, Gil Ben-David, Yehonatan Weinberger

|Nov 29, 2021
Outcomes of Combined Scleral Buckling Plus Pneumatic Retinopexy Vs. Scleral Buckling for Primary Rhegmatogenous Retinal Detachment.

Yehonatan Weinberger, Amir Sternfeld, Natalie Hadar-Cohen

|Mar 03, 2021
Activated Protein C (APC) and 3K3A-APC-Induced Regression of Choroidal Neovascularization (CNV) Is Accompanied by Vascular Endothelial Growth Factor (VEGF) Reduction.

Tami Livnat, Yehonatan Weinberger, José A Fernández

|Feb 15, 2021
Simultaneous bilateral or sequential DCR? What to choose?

Yehonatan Weinberger, Ethan Soudry, Inbal Avisar

Pageof 1

Frequent Collaborators

3 joint publications

Tami Livnat

3 joint publications

José A Fernández

2 joint publications

Ivan Budnik

2 joint publications

Dahlia Palevski